Q3 Revenue Jumps 43% to $30.8M as Operating Margin Triples; Guidance Raised
PAYS has more than doubled off its 52-week low of $3.08 on elevated volume (2.8× avg).
Summary
Paysign beat its own Q3 guidance across the board: revenue rose 42.6% to $30.8M, operating margin jumped to 23.8% from 7.3%, and GAAP net income more than tripled to $6.74M ($0.11 diluted EPS), with gross margin at 64.7%. Pharma patient affordability did the heavy lifting, with revenue up 109.8% to $16.62M and 62 net new programs added over the past year, exiting at 167 active programs. The company confirmed full-year 2026 revenue of $114.0M-$117.0M but raised its profitability outlook for gross margin, net income, EPS and Adjusted EBITDA. The offsetting negative: a plasma customer will move payment processing for 113 centers to another provider by year-end, taking $11.3M of trailing revenue and $5.2M of gross profit with it, with a $1.5M revenue hit expected in Q4. Management says pharma growth more than offsets that loss, and the earnings call is at 5 p.m. ET today.
At the time of this announcement, PAYS was trading at $12.33 on NASDAQ in the Technology sector, with a market capitalization of approximately $706.3M. The 52-week trading range was $3.08 to $16.15. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.